Pitavastatin in cardiometabolic disease: therapeutic profile

Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy

(2012) Alfonso Bellia et al.   ATHEROSCLEROSIS

Statins are diabetogenic – Myth or reality?

(2012) Naveed Sattar et al.   ATHEROSCLEROSIS SUPPLEMENTS

Effects of Steady-State Lopinavir/Ritonavir on the Pharmacokinetics of Pitavastatin in Healthy Adult Volunteers

(2012) Roger E. Morgan et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: The PREMIUM Study

(2012) Tatsuaki Matsubara et al.   Journal of Cardiology

Comparative efficacy of pitavastatin and simvastatin in high-risk patients: a randomized controlled trial

(2011) Mats Eriksson et al.   ADVANCES IN THERAPY

Pitavastatin: Clinical effects from the LIVES Study

(2011) Tamio Teramoto   ATHEROSCLEROSIS SUPPLEMENTS

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations

(2011) Jacques Genest et al.   CANADIAN JOURNAL OF CARDIOLOGY

Randomized Head-to-Head Comparison of Pitavastatin, Atorvastatin, and Rosuvastatin for Safety and Efficacy (Quantity and Quality of LDL)

(2011) Keijiro Saku et al.   CIRCULATION JOURNAL

Comparison of Preventive Effect on Cardiovascular Events With Different Statins

(2011) Takao Maruyama et al.   CIRCULATION JOURNAL

Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin

(2011) Christine Y. Yu et al.   CURRENT MEDICAL RESEARCH AND OPINION

Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia

(2011) J. Gumprecht et al.   DIABETES OBESITY & METABOLISM

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

(2011) M. John Chapman et al.   EUROPEAN HEART JOURNAL

Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy

(2011) David Preiss   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of Pitavastatin on Lipid Profiles and High-Sensitivity CRP in Japanese Subjects with Hypercholesterolemia: Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology (KISHIMEN) Investigatars

(2011) Hiroyuki Koshiyama et al.   Journal of Atherosclerosis and Thrombosis

Effects of Pitavastatin (LIVALO Tablet) on High Density Lipoprotein Cholesterol (HDL-C) in Hypercholesterolemia Sub-Analysis of LIVALO Effectiveness and Safety (LIVES) Study

(2011) Tamio Teramoto et al.   Journal of Atherosclerosis and Thrombosis

Effects of Pitavastatin (LIVALO Tablet) on the Estimated Glomerular Filtration Rate (eGFR) in Hypercholesterolemic Patients with Chronic Kidney Disease

(2011) Kenjiro Kimura et al.   Journal of Atherosclerosis and Thrombosis

Molecular Mechanisms of HDL-Cholesterol Elevation by Statins and Its Effects on HDL Functions

(2011) Shizuya Yamashita et al.   Journal of Atherosclerosis and Thrombosis

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of High-Density Lipoproteins on Pancreatic β-Cell Insulin Secretion

(2010) Michelle A. Fryirs et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Diabetes Mellitus Is a Major Negative Determinant of Coronary Plaque Regression During Statin Therapy in Patients With Acute Coronary Syndrome

(2010) Takafumi Hiro et al.   CIRCULATION JOURNAL

Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2

(2010) Arnold von Eckardstein et al.   CURRENT OPINION IN LIPIDOLOGY

New evidence on pitavastatin: efficacy and safety in clinical studies

(2010) Tamio Teramoto et al.   EXPERT OPINION ON PHARMACOTHERAPY

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Meta-analysis of Comparative Efficacy of Increasing Dose of Atorvastatin Versus Rosuvastatin Versus Simvastatin on Lowering Levels of Atherogenic Lipids (from VOYAGER)

(2009) Stephen J. Nicholls et al.   AMERICAN JOURNAL OF CARDIOLOGY

Evaluating the Incremental Benefits of Raising High-Density Lipoprotein Cholesterol Levels During Lipid Therapy After Adjustment for the Reductions in Other Blood Lipid Levels

(2009) Steven A. Grover et al.   ARCHIVES OF INTERNAL MEDICINE

Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia

(2009) Leiv Ose et al.   ATHEROSCLEROSIS

High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus

(2009) Brian G. Drew et al.   CIRCULATION

A systematic review and meta-analysis on the therapeutic equivalence of statins

(2009) T.-C. Weng et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database

(2009) Philip J. Barter et al.   JOURNAL OF LIPID RESEARCH

Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome

(2009) Takafumi Hiro et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients

(2008) Koutaro Yokote et al.   ATHEROSCLEROSIS

A 52-Week, Randomized, Open-Label, Parallel-Group Comparison of the Tolerability and Effects of Pitavastatin and Atorvastatin on High-Density Lipoprotein Cholesterol Levels and Glucose Metabolism in Japanese Patients with Elevated Levels of Low-Density Lipoprotein Cholesterol and Glucose Intolerance

(2008) J SASAKI et al.   CLINICAL THERAPEUTICS

Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases

(2008) Eileen E. Ming et al.   Journal of Clinical Lipidology

Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis

(2008)   LANCET

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE